Answers are grounded in this paper and cite their sources.
Helminth infections remain a major global health burden, and growing resistance to existing anthelmintic drugs necessitates the development of novel therapeutic agents. The present study evaluated the anthelmintic potential of Ficus hispida L.f. leaf extracts using integrated phytochemical, in vitro, and in silico approaches. Leaf extracts prepared by Soxhlet extraction and cold maceration using solvents of varying polarities were tested against Pheretima posthuma, with albendazole as the reference drug. The ethanolic Soxhlet extract induced rapid paralysis in 2.98 ± 0.17 min and death in 5.31 ± 0.07 min at 100 mg/mL. GC–MS analysis identified several pharmacologically relevant compounds. Molecular docking against β-tubulin demonstrated strong binding affinities, particularly for 9-Phenanthrenemethyl 2,6-dimethylbenzoate (−6.872 kcal/mol), followed by Thebaol (−6.135 kcal/mol) and 2-(1-Phenyl ethylidene-hydrazono)-3-methyl-2,3-dihydrobenzothiazole (−5.850 kcal/mol), suggesting microtubule disruption as a possible mechanism of action. These findings support F. hispida as a promising source of plant-derived anthelmintic agents.
No takes yet. Share an insight, caveat, or question.
Jeyakumar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: